The Week Ahead: COS...
Health Care: Drugs
CEL-SCI Corporation (CVM: AMEX)
$0.25 0.00 | -0.40%
05/24/13 - 04:00 PM ET
488.93K / 1.09M
Vol / Avg. Vol:0.25 / 0.25
Open / Prev. Close:0.25 - 0.25
Today's Range:0.21 - 0.47
52 Wk Range:-5.19%
Performance YTD:TheStreet Rating:
Portfolios with CVM
- Portfolio NameUser Type
- Usermoney maker
- UserDon't Lose My Butthole This...
- User1st Time out
- Userherb's portfolio
- UserBlue OAK
- Usercgimene Portfolio 1
- Userjjkohls Portfolio 1
- UserRet2009
- UserJLR
- Userrschurchill Portfolio 1
Latest CVM Headlines from TheStreet
- BioCryst Won't Profit From Bird Flu Outbreak in China 04.08.13 | 03:04 pm
- CEL-SCI Stock Gaps Down On Today's Open (CVM) 05.31.12 | 10:05 am
- Biotech Stock Mailbag: Ampio, Cel-Sci and Ziopharm 04.05.12 | 05:04 am
- Biotech Data Mining Comes Up Empty 06.29.11 | 07:06 am
- Cel-Sci Settles Over South African Partner Flap 05.17.11 | 09:05 am
- Cel-Sci: The Multikine Sweet 16 05.03.11 | 12:05 pm
- Sweet Spot in Biotech Investing 04.13.11 | 12:04 pm
- Biotech Stock Mailbag: Exact Sciences 02.25.11 | 07:02 am
- Biotech Stock Mailbag: Orexigen Therapeutics 01.28.11 | 07:01 am
- Biotech Stock Mailbag: Vivus 09.24.10 | 07:09 am
Press Releases for CVM
- CEL-SCI Announces Initiation Of New Sites For Multikine Phase III Clinical Study For Head And Neck Cancer In Taiwan - Business Wire 02.25.13 | 10:02 am
- CEL-SCI Corporation Reports First Quarter 2013 Financial Results - Business Wire 02.08.13 | 04:02 pm
- CEL-SCI To Present At 15th Annual BIO CEO & Investor Conference - Business Wire 02.07.13 | 08:02 am
- CEL-SCI And Northeast Ohio Medical University Develop Novel Cancer Vaccine That Prevents And Treats Breast Cancer - Business Wire 01.31.13 | 09:01 am
- CEL-SCI Corporation Announces Fiscal 2012 Financial Results - Business Wire 12.14.12 | 04:12 pm
- CEL-SCI Corporation To Raise $10.5 Million In Registered Direct Offering - Business Wire 12.04.12 | 09:12 am
- CEL-SCI Corporation Releases Letter To Shareholders - Business Wire 11.30.12 | 09:11 am
- CEL-SCI Receives Key Japanese Patent For Its Investigational Phase III Cancer Therapy Multikine - Business Wire 11.28.12 | 10:11 am
- CEL-SCI Corporation Announces Results Of Interim Review Of Data From Its Ongoing Phase III Head And Neck Cancer Trial By Independent Data Monitoring Committee (IDMC) - Business Wire 10.22.12 | 10:10 am
- CEL-SCI Corporation Reports Third Quarter 2012 Financial Results - Business Wire 08.09.12 | 04:08 pm
Partner Headlines for CVM
- CEL-SCI Corporation to Raise $10.5M in Registered Direct Offering - Benzinga 12.04.12 | 09:12 am
- 4 Undervalued And Technically Oversold Healthcare Penny Stocks Poised To Bounce - Seeking Alpha 11.20.12 | 09:11 am
- 3 High Beta Liquid Small-Cap Biotechnology Stocks That Are Breaking Out - Seeking Alpha 09.17.12 | 09:09 am
- Astex's Linear Rise Versus Peregrine's And Cell Therapeutics' Sudden Pop - Seeking Alpha 09.10.12 | 09:09 am
- Stocks To Watch: Week Of March 19-23 - Seeking Alpha 03.21.12 | 08:03 am
- With Neptune, Opportunity Is Knockin' - Seeking Alpha 03.19.12 | 09:03 am
- Cel-Sci Offers Huge Potential Gains With Revolutionary Immunotherapy Anti-Cancer Drug - Seeking Alpha 03.13.12 | 09:03 am
- Immunocellular Again Pushing To $2 - Seeking Alpha 02.15.12 | 09:02 am
- 2 Biotechs On Teva's Radar Screen - Seeking Alpha 02.06.12 | 08:02 am
- Biopharma Stocks To Watch This Week - Seeking Alpha 01.19.12 | 09:01 am
